Shilpa Medicare Ltd. Financials

NSE BSE

15:52 Jul 18

Shilpa Medicare Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

915.70

-6.85 (-0.74%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

915.70

-6.85 (-0.74%)
15:52 Jul 18

Quality

88/100
High Financial Strength

Valuation

35/100
Mid Valuation

Technical

64/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Sales	901.13	1145.52	1050.11	1151.6	1286.41
Operating Expenses +	719.47	941.66	947.83	907.11	969.37
Raw Material	329.56	390.24	404.43	442.33	372.75
Increase Decrease in Cost	-58.83	-7.02	11.5	-34.78	37.61
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	235.31	264.49	287.33	281.49	292.71
Miscellaneous Expenses	234.79	310.93	312.55	254.09	311.26
Operating Profit	181.66	203.86	102.28	244.49	317.04
Other Income	30.14	14.25	17.4	8.17	23.15
Depreciation	53.98	79.8	95.5	107.87	112.99
Interest	21.87	41.17	58.65	91.81	75.53
Profit before tax and exceptio..	135.95	97.13	-34.47	52.99	151.68
Exceptional Items	60.84	8.79	0	6.13	-28.08
PBT	196.79	105.93	-34.47	59.12	123.6
Provision for Taxation	48.85	41.68	-7.36	22.39	44.04
Net Profit	147.94	64.24	-27.11	36.73	79.56
NET Profit after MI	147.78	60.66	-32.48	31.87	78.29
EPS	18.13	7.26	-3.74	3.67	8.04
Operating Profit Margin (%)	20.16	17.8	9.74	21.23	24.65
Net Profit Margin (%)	16.4	5.3	-3.09	2.77	6.09

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	44.20	44.20	44.20	44.30	44.40
FII	11.20	11.00	9.90	9.60	9.10
MF	4.00	4.00	4.90	5.10	5.00
Others	3.40	3.50	3.40	3.10	2.60

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: